Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Frank

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 25, 2013
Treatment of Huntington's diseaseSamuel Frank
Neuropsychiatric Disease and Treatment|October 20, 2010
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington diseaseSamuel Frank
BMC Neurology|December 22, 2009
Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD InvestigatorsSamuel Frank
Neurodegenerative Disease Management|January 10, 2019
Deutetrabenazine in the treatment of Huntington's diseaseAlby Richard, Samuel Frank
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2005
Trauma-induced spinal vascular event producing hemipseudoathetosisSamuel Frank, Richard Barbano
PET Clinics|May 10, 2016
Epidemiology and Clinical Diagnosis of Parkinson DiseaseMichael Kleinman, Samuel Frank
Therapeutics and Clinical Risk Management|December 11, 2023
Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive DyskinesiaSamuel Frank, Aljoharah Alakkas
Neurology|July 23, 2003
Medical errors on an inpatient neurology serviceSamuel Frank, Robert Holloway
Drugs|March 25, 2010
Advances in the pharmacological management of Huntington's diseaseSamuel Frank, Joseph Jankovic
The Permanente Journal|January 23, 2021
A Clinical Approach to Catamenial Epilepsy: A ReviewSamuel Frank, Nichole A Tyson
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 25, 2013
Treatment of Huntington's diseaseSamuel Frank
Neuropsychiatric Disease and Treatment|October 20, 2010
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington diseaseSamuel Frank
BMC Neurology|December 22, 2009
Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD InvestigatorsSamuel Frank
Neurodegenerative Disease Management|January 10, 2019
Deutetrabenazine in the treatment of Huntington's diseaseAlby Richard, Samuel Frank
Movement Disorders : Official Journal of the Movement Disorder Society|July 12, 2005
Trauma-induced spinal vascular event producing hemipseudoathetosisSamuel Frank, Richard Barbano
PET Clinics|May 10, 2016
Epidemiology and Clinical Diagnosis of Parkinson DiseaseMichael Kleinman, Samuel Frank
Therapeutics and Clinical Risk Management|December 11, 2023
Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive DyskinesiaSamuel Frank, Aljoharah Alakkas
Neurology|July 23, 2003
Medical errors on an inpatient neurology serviceSamuel Frank, Robert Holloway
Drugs|March 25, 2010
Advances in the pharmacological management of Huntington's diseaseSamuel Frank, Joseph Jankovic
The Permanente Journal|January 23, 2021
A Clinical Approach to Catamenial Epilepsy: A ReviewSamuel Frank, Nichole A Tyson
Pageof 8